Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring

被引:10
作者
Azar, Nabil J. [1 ]
Wang, Lily [2 ]
Song, Yanna [2 ]
Abou-Khalil, Bassel W. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
关键词
withdrawal seizures; epilepsy monitoring; rebound phenomenon; oxcarbazepine; phenytoin;
D O I
10.1016/j.eplepsyres.2007.12.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To compare the temporal pattern of seizures after acute withdrawal of oxcarbazepine (OXC) and phenytoin (PHT) in the epilepsy monitoring unit (EMU). Methods: We identified all epilepsy patients admitted to our EMU on OXC or PHT monotherapy, over a period of 5 years. The OXC taper usually occurred over 2 days while PHT was abruptly discontinued on admission day. For each patient, we recorded the number and type of seizures for each EMU day. We used Poisson regression models to estimate daily seizure frequency separately for complex partial seizures (CPSs) and generalized tonic-clonic seizures (GTCSs). Results: Forty patients were admitted on OXC and 32 on PHT monotherapy. The temporal distribution of seizures varied between the two groups. The first GTCS was more likely to occur in the first 2 days of monitoring for the OXC group (p < 0.046). There was a higher frequency of GTCS on day 2 of admission in the OXC group (p = 0.011). The groups did not differ in the pattern of CPS. Conclusions: OXC is disproportionately associated with increased GTCS in the first 2 days after acute withdrawal. The early peak of GTCS favors a rebound phenomenon in addition to loss of therapeutic effect. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 15 条
[1]  
AZAR N, IN PRESS NEUROLOGY
[2]   PHENYTOIN WITHDRAWAL AND SEIZURE FREQUENCY [J].
BROMFIELD, EB ;
DAMBROSIA, J ;
DEVINSKY, O ;
NICE, FJ ;
THEODORE, WH .
NEUROLOGY, 1989, 39 (07) :905-909
[3]   Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study [J].
Chadwick, D .
BRAIN, 1999, 122 :441-448
[4]   Increased seizures after discontinuing carbamazepine: Results from the gabapentin monotherapy trial [J].
DeToledo, JC ;
Ramsay, RE ;
Lowe, MR ;
Greiner, M ;
Garofalo, EA .
THERAPEUTIC DRUG MONITORING, 2000, 22 (06) :753-756
[5]   DISCONTINUATION OF PHENYTOIN, CARBAMAZEPINE, AND VALPROATE IN PATIENTS WITH ACTIVE EPILEPSY [J].
DUNCAN, JS ;
SHORVON, SD ;
TRIMBLE, MR .
EPILEPSIA, 1990, 31 (03) :324-333
[6]   Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal [J].
Lee, HW ;
Seo, HJ ;
Cohen, LG ;
Bagic, A ;
Theodore, WH .
CLINICAL NEUROPHYSIOLOGY, 2005, 116 (05) :1105-1112
[7]  
LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13
[8]   CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF OXCARBAZEPINE [J].
LLOYD, P ;
FLESCH, G ;
DIETERLE, W .
EPILEPSIA, 1994, 35 :S10-S13
[9]   RELATIONSHIP OF CARBAMAZEPINE REDUCTION RATE TO SEIZURE FREQUENCY DURING INPATIENT TELEMETRY [J].
MALOW, BA ;
LYNCH, B ;
BLAXTON, TA ;
MIKATI, MA .
EPILEPSIA, 1994, 35 (06) :1160-1164
[10]   CARBAMAZEPINE WITHDRAWAL - EFFECTS OF TAPER RATE ON SEIZURE FREQUENCY [J].
MALOW, BA ;
BLAXTON, TA ;
STERTZ, B ;
THEODORE, WH .
NEUROLOGY, 1993, 43 (11) :2280-2284